Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul F Mercer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Thorax|August 7, 2016
Evidence for chemokine synergy during neutrophil migration in ARDSAndrew E Williams, Ricardo J José, Paul F Mercer, et al.
American Journal of Respiratory and Critical Care Medicine|March 6, 2010
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosisToby M Maher, Iona C Evans, Stephen E Bottoms, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2008
Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosisPaul F Mercer, Robin H Johns, Chris J Scotton, et al.
Science Signaling|May 23, 2019
mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β<sub>1</sub>-induced collagen biosynthesisBrintha Selvarajah, Ilan Azuelos, Manuela Platé, et al.
Thorax|November 20, 2020
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesisDelphine Guillotin, Adam R Taylor, Manuela Platé, et al.
The Journal of Clinical Investigation|August 5, 2009
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injuryChris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, et al.
Thorax|April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFPaul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Nature Communications|January 4, 2019
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Thorax|August 7, 2016
Evidence for chemokine synergy during neutrophil migration in ARDSAndrew E Williams, Ricardo J José, Paul F Mercer, et al.
American Journal of Respiratory and Critical Care Medicine|March 6, 2010
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosisToby M Maher, Iona C Evans, Stephen E Bottoms, et al.
American Journal of Respiratory and Critical Care Medicine|December 9, 2008
Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosisPaul F Mercer, Robin H Johns, Chris J Scotton, et al.
Science Signaling|May 23, 2019
mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β<sub>1</sub>-induced collagen biosynthesisBrintha Selvarajah, Ilan Azuelos, Manuela Platé, et al.
Thorax|November 20, 2020
Transcriptome analysis of IPF fibroblastic foci identifies key pathways involved in fibrogenesisDelphine Guillotin, Adam R Taylor, Manuela Platé, et al.
The Journal of Clinical Investigation|August 5, 2009
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injuryChris J Scotton, Malvina A Krupiczojc, Melanie Königshoff, et al.
Thorax|April 23, 2016
Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPFPaul F Mercer, Hannah V Woodcock, Jessica D Eley, et al.
The European Respiratory Journal|February 16, 2019
A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosisPauline T Lukey, Stephen A Harrison, Shuying Yang, et al.
Nature Communications|September 12, 2020
Author Correction: The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Nature Communications|January 4, 2019
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesisHannah V Woodcock, Jessica D Eley, Delphine Guillotin, et al.
Pageof 3